Skip to main content

Month: December 2020

Solutions 30 : PRESS RELEASE – TRADING HALT

As a provisional measure, Solutions 30 (FR0013379484) announces that trading of its ordinary shares on the regulated market of Euronext in Paris has been halted at the Company’s request from 9:00 am CET, in the context of further attempts to destabilise the company and its shares.This trading halt is effective from today’s market opening until further communication is released in due course. About Solutions 30 SEThe Solutions 30 group is the European leader in solutions for new technologies. Its mission is to make the technological developments that are transforming our daily lives accessible to everyone, individuals and businesses alike. Yesterday, it was computers and the Internet. Today, it’s digital technology. Tomorrow, it will be technologies that make the world even more interconnected in real time. With more than 30 million call-outs...

Continue reading

GreenMobility to list on Nasdaq Copenhagen’s Main Market

Company Announcement no. 74 – 2020Copenhagen, December 11th, 2020GreenMobility to list on Nasdaq Copenhagen’s Main MarketWith reference to company announcement no. 69 2020 dated 7 October 2020, GreenMobility A/S (“GreenMobility”) today announces that it has initiated a process for admission to trading and official listing of the GreenMobility’s shares on the Nasdaq Copenhagen’s Main Market. Thereby, GreenMobility will transfer from the shares’ current trading platform on Nasdaq First North Growth Market Denmark. There will not be any offering of securities for sale or subscription in connection with the listing.GreenMobility has decided to submit an application for deletion of the shares from trading on Nasdaq First North Growth Market Denmark in connection with and conditional upon an application for its shares to be admitted to trading...

Continue reading

Cataract Surgical Devices Market to Reach USD 9.98 Billion with Rise at 5.4% CAGR by 2026; Increasing Number of Product Launches to Aid Growth, says Fortune Business Insights™

Pune, Dec. 11, 2020 (GLOBE NEWSWIRE) — The global cataract surgical devices market size is projected to reach USD 9.98 billion by the end of 2026. The high prevalence of cataract disorders will open up a huge potential for market growth. The market was worth USD 6.56 billion in 2018 and will exhibit a CAGR of 5.4% during the forecast period, 2019-2026. The increasing prevalence of cataract disorders and growing use of technologically advanced devices. As of 2018, the market in Asia Pacific was worth USD 2.09 billion and this value is likely to increase in the coming years.INDUSTRY DEVELOPMENTS:February 2017: Johnson & Johnson Services, Inc. announced the completion of acquisition of Abbott Medical Optics, a subsidiary of Abbott for an estimated USD 4 Bn. This acquisition includes devices of cataract surgery manufactured by...

Continue reading

Bone Therapeutics announces pricing of private placement

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SOGosselies, Belgium, 11 December 2020, 8am CET – BONE THERAPEUTICS SA (Euronext Brussels and Paris: BOTHE; or “Bone Therapeutics”), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces that it has entered into subscription agreements with investors to purchase up to 4,408,881 new shares at an issue price of EUR 2.25 per share resulting in gross proceeds of approximately EUR 10 million (the “Private Placement“).“Achieving this successful private placement will enable Bone Therapeutics to firmly advance therapies from our cutting-edge allogeneic MSC platform...

Continue reading

Bone Therapeutics réalise un placement privé

LE PRÉSENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, TOTALEMENT OU PARTIELLEMENT, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, EN AUSTRALIE, AU CANADA, AU JAPON, EN AFRIQUE DU SUD, OU DANS TOUT AUTRE JURIDICTION INTERDISANT DE TELLES PRATIQUESGosselies, Belgique, le 11 décembre 2020, 8h CET – BONE THERAPEUTICS SA (Euronext Bruxelles et Paris : BOTHE ; ou « Bone Therapeutics »), société de biotechnologie spécialisée dans le développement de thérapies cellulaires innovantes répondant aux besoins médicaux non satisfaits en orthopédie et dans d’autres pathologies graves, annonce aujourd’hui la conclusion d’accords de souscription avec des investisseurs pour l’achat de jusqu’à 4 408 881 nouvelles actions à un prix d’émission de 2,25 euros par action pour un produit brut d’environ 10 millions d’euros (le « Placement Privé »).« Ce...

Continue reading

Global Endoscopic Ultrasound Market to Touch USD 1,375.6 Million with a CAGR of 6.5% by 2026; Increasing Number of Medical Professionals to Stimulate Growth: Fortune Business Insights™

Pune, India, Dec. 11, 2020 (GLOBE NEWSWIRE) — The global Endoscopic Ultrasound Market size is projected to reach USD 1,375.6 million by 2026, registering a CAGR of 6.5% during the forecast period. The market value stood at USD 830.6 Million in 2018. With a revenue generation of USD 296.9 Million in 2018, North America is set to occupy a commanding position in the EUS market till 2026.INDUSTRY DEVELOPMENT:August 2017: PENTAX Medical announced the launch of the Slim Linear Ultrasound Endoscope (EG-3270UK) in the U.S.June 2018: Olympus Corporation announced a strategic alliance with Hitachi Medical Systems Europe as a result of which Olympus’ endoscopic ultrasound sonography (EUS) scopes will now be compatible with Hitachi’s ultrasound system ARIETTA 850 ENDOSCOPIC.May 2018: Olymbus Corporation and Hitachi Healthcare Americas announced...

Continue reading

Company Announcement 11/2020

December 11, 2020NORDIC SHIPHOLDING A/S Company Announcement: 11/2020Loan extension & restructuring, write down and revised Outlook 2020Loan extension & restructuring and write downWith reference to Company Announcement 10/2020 following successful negotiations between the major shareholder, management and the lenders, an agreement has been reached with the lenders for an extension of the Company’s loan facility by another year to 31 December 2021.This loan extension and restructuring gives the Company more time to explore various scenarios, including the possibility of a merger, that to date have been negatively impacted by the effects of the Covid-19 pandemic. In order to conclude the restructuring, the Company has agreed to pursue the sale of two vessels, i.e. the Nordic Hanne and Nordic Pia.  Consequently, the Nordic Pia...

Continue reading

Selskabsmeddelelse 11/2020

11. december, 2020Nordic Shipholding A / SSelskabsmeddelelse: 11/2020 Offentliggjort via NASDAQ OMX den 11. december, 2020.Låneforlængelse og restrukturering, nedskrivning ogopdaterede forventninger til regnskabsåret 2020.Låneforlængelse og restrukturering, nedskrivningMed henvisning til Selskabsmeddelelse 10/2020 er der efter succesfulde forhandlinger mellem koncernens hovedaktionær, koncernens ledelse og långiverne opnået en aftale med långiverne om en forlængelse af selskabets lånefaciliteter med et år til 31. december 2021.Denne forlængelse og restrukturering af lånefaciliteterne giver koncernen yderligere tid til at forfølge forskellige scenarier, herunder en mulig fusion, som til dato er blevet negativt påvirket af følgerne af Covid-19 pandemien.Som led i restrukturering af lånefaciliteterne, har selskabet aftalt at skulle sælge...

Continue reading

NB Private Equity: Investor Update Webinar

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSNB Private Equity Partners Announces Investor Update Webinar11 December 2020NB Private Equity Partners Limited (“NBPE” or the “Company”) today announced that an investor update will be held on Wednesday 16 December 2020 via Zoom in order to discuss year to date performance, the investment portfolio and Company developments.The webinar will take place at 13.00 GMT / 14.00 CET / 8.00 EST.  The call can be accessed via the Zoom call details below:Join from a PC, Mac, iPad, iPhone or Android device:Please click this URL to join. https://nb.zoom.us/s/91373094346?pwd=UFpIT3c4cU8weXRXWG81ZExSaWtDUT09Webinar ID: 913 7309 4346Passcode: 564319Or join by phone:   ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.